AdobeStock_167933361_OUD.jpeg

Opioid Use Disorder (OUD)

Mozzaz Solutions for Individuals, Families, and Professionals

Support higher levels of care plan adherence and retention through interactive and always-accessible interventions and support. 

The cost of the opioid epidemic in the US has climbed to an estimated $1 trillion and costs related to the crisis are increasing at an accelerating rate. Opioid substitution therapy with buprenorphine can play a key, and sometimes lifesaving, role in the treatment of opioid use disorder. However, the adherence, management and retention rates of buprenorphine are less than 50% leading to high rates of relapse.

in 2016, over 11 million Americans misused prescription opioids, nearly 1 million used heroin, and 2.1 million had an opioid use disorder due to prescription opioids or heroin. Since 2000, more than 300,000 Americans have died of an opioid overdose. Preliminary data for 2016 indicate at least 64,000 drug overdose deaths, the highest number ever recorded in the U.S.

 

Mozzaz provides patients with a solution to log and journal their use of buprenorphine along with tracking symptoms and behavior. Patient collected data is monitored by clinical teams with alerts based on mediation adherence, urges, physical health and behavior changes. In addition, clinical teams can include interactive patient education, social media support and psychotherapy interventions as part of an individual’s treatment plan. Clinical teams can also use Mozzaz TALK to observe behavior and monitor medication administration through a secure video call.

More efficient care delivery


patient-icon
 

Patient

 

  • Reminders of medication dosages and scheduled times
  • Convenient medication tracking and logging of symptoms
  • Remote clinical team support through telehealth observations and sessions
OUD_Patient.PNG

provider-icon
 

Provider

SUPPORT GROUP COORDINATOR, CLINICIANS,
NURSE PRACTITIONERS

  • Remotely monitor safe usage of medication in treatment
  • Improve patient retention rates and adherence to MAT plans through patient engagement tools
  • Support adherence through telehealth video observations of medication usage and health status
OUD_Prof.png

 Everything you need for the results you want


Features

feature-icons_Artboard 1.png

Psychotherapy interventions
to support coping mechanisms & prevent relapse

feature-icons-02.png

Automated schedules and
reminders for medication
treatment

feature-icons-03.png

Patient-reported MAT journals
and diaries

feature-icons-04.png

Clinician remote patient care
with alerts and telehealth
observations and sessions


Results

Increase adherence to MAT care plans

Increase rate of abstinence of all opiate use

Decrease rate of necessary opiate usage

The immediate insight we’re getting through real-time monitoring allows us to be responsive and proactive before a harmful episode”

—Jennifer Armstrong, VP Client Engagement, Centerstone

Serious Mental Illness (SMI)

Substance Use Disorder (SUD)

Opioid Use Disorder

Foster Care

Disability and Long-Term Care

Crisis Support

Suicide Prevention

Chronic Disease Management